AVENIO ctDNA Surveillance Kit

DEVICE3 trials

Sponsors

Shanghai Zhongshan Hospital, Stanford University, Maximilian Diehn

Conditions

Gastric CancerNSCLC, Stage IIINon Small Cell Lung CancerNon-small Cell Lung CancerNon-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage IIINsclc

Phase 2

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

SuspendedNCT04585477

Stanford UniversityNon-small Cell Lung Cancer, Non-small Cell Lung Cancer Stage I, Non-small Cell Lung Cancer Stage II +1

Start: 2021-04-08End: 2026-12-30Target: 80Updated: 2026-07-07

Phase 3

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

RecruitingNCT04585490

Maximilian DiehnNon Small Cell Lung Cancer, Nsclc, NSCLC, Stage III

Start: 2021-08-25End: 2028-04-01Target: 48Updated: 2026-05-04

Unknown Phase

Potential Clinical Utilities of Circulating Tumor DNA in Gastric Cancer

Shanghai Zhongshan HospitalGastric Cancer

Start: 2018-12-01End: 2021-05-31Target: 55Updated: 2019-06-27